Migraine-Related Burden, Treatment Interventions, and Healthcare Experiences by Race and Ethnicity: Results of the Migraine Report Card Survey

Résumé fourni par la source

Migraine studies consistently have low enrollment of non-White and/or Hispanic participants. This exploratory analysis assesses burden, treatment interventions, and care in people with high-frequency migraine and medication overuse (HFM + MO) in three racial/ethnic groups in the United States that responded to the Migraine Report Card online survey. The Migraine Report Card survey was fielded to adults (≥ 18 years). Eligible respondents reported current or previous HFM + MO (≥ 8 days/month with headache and ≥ 10 days/month of acute headache medication use over the last few months) and screened positive for migraine using the ID Migraine™ screener. Survey questions pertained to living with migraine, healthcare-patient communication, and treatment use and access. Subgroups large enough for analysis included non-Hispanic White, non-Hispanic Black, and Hispanic respondents currently experiencing HFM + MO. Acute medication optimization was assessed with the 4-item Migraine Treatment Optimization Questionnaire. Raw data were weighted to the US adult population. A total of 414 respondents currently experiencing HFM + MO were included in this analysis (White, n = 293; Black, n = 46; Hispanic, n = 75). In this population, despite similarities in migraine and insurance status, 54% of Black respondents reported being "very concerned" about their current health compared to 29% of White and 24% of Hispanic respondents. Twenty percent of White respondents reported using a preventive prescription migraine medication compared to 7% of Black and 10% of Hispanic respondents. Despite similar clinical and socioeconomic characteristics, healthcare disparities were observed, most notably among Black and Hispanic respondents experiencing HFM + MO. Further research regarding inequities in migraine care and disease impact is needed.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.